Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Indication

Chronic Abnormal Immune Activation in HIV/AIDS

1 clinical trial

2 products

Product
T8
Clinical trial
Efficacy and Safety of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients: A Multicenter, Randomized, Double-blind, Dose-finding, Placebo-controlled Study
Status: Completed, Estimated PCD: 2022-07-05
Product
Placebo